Quantcast

Latest Metformin Stories

2014-09-11 16:26:05

Results from Phase 2b Clinical Study in Patients with Type 2 Diabetes Provide Evidence that SGLT1 inhibition with LX4211 Provides a Clinically Meaningful Benefit THE WOODLANDS, Texas, Sept. 11, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced a publication in the online edition of the American Diabetes Association's journal, Diabetes Care, entitled, "Greater Dose-Ranging Effects on A1C Levels Than on Glucosuria With LX4211, a Dual Inhibitor of Sodium...

prediabetes cancer risk
2014-09-10 06:33:34

April Flowers for redOrbit.com - Your Universe Online Professor Yuli Huang of The First People's Hospital of Shunde, China, worked with a team of researchers to conduct a meta-analysis of studies concerning prediabetes. Their findings, published in Diabetologia, are based on 16 studies and 891,426 participants from around the world. The literature review revealed that people with prediabetes have a 15 percent higher risk of developing cancer — and that the level of risk differs depending...

2014-08-28 12:30:33

No overall statistically significant increased risk of bladder cancer in patients ever exposed to pioglitazone in a completed 10-year epidemiological study OSAKA, Japan, Aug. 28, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") today announced the completion of the post-marketing commitment and submissions of data from a 10-year epidemiology study to regulatory authorities including the United States (U.S.) Food and Drug Administration (FDA), the European Medicines Agency...

diabetes drug metformin
2014-08-11 04:19:36

April Flowers for redOrbit.com - Your Universe Online A large-scale study from Cardiff University, involving over 180,000 people, reveals that people with Type 2 diabetes can live longer than those without the condition, thanks to a widely prescribed blood glucose control medication. The findings, published in Diabetes, Obesity and Metabolism, suggest that metformin — commonly used to control glucose levels in the body and known for exhibiting anticancer properties — could offer...

2014-08-08 20:22:12

In Phase 3 studies, INVOKANA® plus metformin lowered blood sugar and reduced secondary endpoints of body weight and systolic blood pressure to a greater degree than metformin alone RARITAN, N.J., Aug. 8, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. announced today the U.S. Food and Drug Administration (FDA) has approved INVOKAMET((TM)), a fixed-dose therapy combining canagliflozin and metformin hydrochloride in a single tablet, for the treatment of adults with type 2 diabetes....

diabetes dynamic duo
2014-08-05 03:30:27

Helmholtz Zentrum München Metformin and SGLT2 inhibitors together reduce the blood sugar levels considerably more effectively than either drug alone. Scientists from the Helmholtz Zentrum München, partner in the German Center for Diabetes Research, report in the journal Diabetes that this is due to a synergetic mechanism. Various active substances in oral antidiabetic agents are frequently combined in the treatment of diabetes in order to achieve an effective reduction in the blood...

2014-08-04 08:29:23

- Combination of linagliptin and metformin significantly reduced blood glucose levels compared with linagliptin alone RIDGEFIELD, Conn. and INDIANAPOLIS, Aug. 4, 2014 /PRNewswire/ -- The U.S. Prescribing Information for Jentadueto® (linagliptin and metformin hydrochloride) tablets now includes clinical trial data that showed linagliptin co-administered with metformin provided statistically significant decreases in blood glucose compared with linagliptin alone in treatment-naive* adults with...

2014-07-15 16:27:20

LONDON, July 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Type 2 Diabetes Global Clinical Trials Review, H1, 2014https://www.reportbuyer.com/product/2160179/Type-2-Diabetes-Global-Clinical-Trials-Review-H1-2014.htmlType 2 Diabetes Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, "Type 2 Diabetes Global Clinical Trials Review, H1, 2014" provides data on the Type 2 Diabetes clinical trial scenario. This report...

Labeling People With Pre-diabetes Is Unhelpful And Unnecessary
2014-07-15 03:31:56

University College London Labeling people with moderately high blood sugar as pre-diabetic is a drastically premature measure with no medical value and huge financial and social costs, say researchers from UCL and the Mayo Clinic, Minnesota. The analysis, published in the BMJ, considered whether a diagnosis of pre-diabetes carried any health benefits such as improved diabetes prevention. The authors showed that treatments to reduce blood sugar only delayed the onset of type 2 diabetes...

2014-06-23 16:24:44

--Microbiome Modulator NM504 Significantly Improved Blood Glucose Control and Other Metabolic Parameters in Patients with Prediabetes and Type 2 Diabetes-- CHICAGO and BROOMFIELD, Colo., June 23, 2014 /PRNewswire/ -- MicroBiome Therapeutics(TM) LLC, (MBT) today presented positive results from a clinical trial of microbiome modulator NM504 in prediabetes and type 2 diabetes at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society....


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.